NCT06305988Completed
Neuroregulatory Effect and Mechanism of tDCS on Medial Prefrontal Cortex in ASD
Neuroregulatory Effect and Mechanism of Transcranial Direct Current Stimulation on Medial Prefrontal Cortex in Autism Spectrum Disorder
Source: ClinicalTrials.gov · Last updated 27 Jun 2024
Brief summary (registry, in English)
In this proposed study, a transcranial direct current stimulator is used to intervene in the medial prefrontal cortex of children with autism, and the efficacy of this intervention method is evaluated, as well as the internal mechanism of Autism Spectrum Disorders' intervention is discussed.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 36 (actual)
- First submitted
- 26 Jan 2024
- Start date
- 1 Aug 2023
- Primary completion date
- 31 May 2024
- Lead sponsor
- Jian-Jun Ou
- Diseases
- Autism
- NCT number
- NCT06305988
What you commit to
- Study type: Interventional
- Participants enrolled: 36
- From 1 Aug 2023 to the primary completion date, 31 May 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- a) Existence of serious physical diseases and conditions, such as significant intracranial lesions, thyroid diseases, epilepsy, congenital heart disease, severe hematological diseases, systemic lupus erythematosus, visual and auditory impairments, etc;
- Imaging examination showed significant brain structural abnormalities;
- Having serious neurological diseases, a clear family history, or potential risks;
- Metal or pacemaker implantation in the body, holes or cracks in the skull;
- Taking benzodiazepines or anticonvulsants;
- The existence of clear or suspicious genetic diseases;
- Conforming to the diagnosis of other serious mental illnesses, such as schizophrenia and bipolar disorder.
Who the study is looking for
- Age 4-18 years old;
- Clinically diagnosed by a psychiatrist with autism spectrum disorder;
- Confirmed by researchers (pediatric psychiatrists) that they meet the diagnostic criteria for autism spectrum disorders in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) of the United States;
- Evaluated by researchers (pediatric psychiatrists) using the Autism Diagnostic Interview Revised (ADI-R) and Autism Diagnostic Observation Schedule (ADOS), it is consistent with the diagnosis of autism spectrum disorders;
- Capable of cooperating with magnetic resonance spectroscopy and transcranial direct current stimulation.
Age in the registry: 4 years to 18 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Psychiatry, Xiangya Second Hospital, Central South University Coordinator of this site? Confirm its status | Changsha | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.